Navellier & Associates Inc. Buys New Shares in Electromed, Inc. (NYSE:ELMD)

Navellier & Associates Inc. acquired a new position in Electromed, Inc. (NYSE:ELMD) in the third quarter, Holdings Channel.com reports. The firm acquired 17,160 shares of the company’s stock, valued at approximately $368,000.

Several other institutional investors have also recently modified their holdings of the company. Hunter Associates Investment Management LLC lifted its position in Electromed by 12.3% in the 3rd quarter. Hunter Associates Investment Management LLC now owns 102,450 shares of the company’s stock worth $2,199,000 after buying an additional 11,250 shares during the last quarter. Marshall Wace LLP bought a new stake in shares of Electromed in the 2nd quarter worth approximately $256,000. Gabelli Funds LLC boosted its stake in shares of Electromed by 7.8% in the 2nd quarter. Gabelli Funds LLC now owns 38,675 shares of the company’s stock valued at $581,000 after purchasing an additional 2,808 shares in the last quarter. Pekin Hardy Strauss Inc. purchased a new stake in shares of Electromed in the 2nd quarter valued at $522,000. Finally, Renaissance Technologies LLC grew its holdings in shares of Electromed by 4.8% during the 2nd quarter. Renaissance Technologies LLC now owns 103,004 shares of the company’s stock valued at $1,548,000 after purchasing an additional 4,736 shares during the last quarter. 40.82% of the stock is currently owned by institutional investors.

Electromed Stock Up 6.1 %

Electromed stock opened at $29.77 on Friday. The firm has a fifty day simple moving average of $23.00 and a two-hundred day simple moving average of $18.11. Electromed, Inc. has a twelve month low of $9.81 and a twelve month high of $30.00. The company has a market capitalization of $251.79 million, a PE ratio of 38.99 and a beta of 0.27.

Electromed (NYSE:ELMD) last issued its earnings results on Tuesday, November 12th. The company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.03 by $0.13. The company had revenue of $14.67 million for the quarter. Electromed had a net margin of 11.34% and a return on equity of 15.32%.

Electromed Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.